NCT05765461|Completed
Loading search results
Sponsor study identifier
observational
4,631
7 countries
7
Study Start
December 31, 2019
Actual (reported)Primary Completion
November 28, 2022
Actual (reported)Study Completion
November 28, 2022
Actual (reported)This study aims at evaluating the effect of a topical product on the improvement of quality of life and pain of patients suffering from atopic dermatitis or other skin diseases with dryness or severe xerosis. Patients aged 16 years and over are asked to apply the product once or twice a day for 2 months. They may be prescribed a corticosteroid upon decision of the dermatologist.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 28, 2022
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 31, 2019
Actual (reported)November 28, 2022
Actual (reported)November 28, 2022
Actual (reported)March 1, 2023
Actual (reported)March 13, 2023
Actual (reported)change in the intensity of skin disease
The dermatologist evaluates the intensity of the skin condition on a 5-point scale (from absent to very severe)
from baseline to Day56
change in the intensity of skin dryness
from baseline to Day56
evolution of the inflammatory lesions surface
from baseline to Day56
change in the intensity of pruritus
from baseline to Day56
change in the quality of sleep
from baseline to Day56
change in the daily discomfort
from baseline to Day56
patients meeting the inclusion criteria and agreeing to participate in the study
Dermatology practices
Zagreb, Croatia
Dermatology practices
Berlin, Germany
Dermatology practices
Lisbon, Portugal
Dermatology practices
Pretoria, South Africa
Dermatology practices
Taipei, Taiwan
Dermatology practices
Bangkok, Thailand
Dermatology practices
Hanoi, Vietnam
Delphine Kerob
Cosmetique Active International
4,631 participants (actual enrollment reported by the registry).
First Submitted
March 1, 2023
First Posted
March 13, 2023
Study Start
December 31, 2019
Actual (reported)Evaluation of Cicaplast in Subjects With Skin Irritation
Contact the study team to confirm eligibility.
Primary Completion
November 28, 2022
Actual (reported)Study Completion
November 28, 2022
Actual (reported)Last Updated
July 1, 2024
Record last verified: 2024-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: